128 related articles for article (PubMed ID: 22996647)
1. Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
Mitchell A; Mathew G; Jiang T; Hamdy FC; Cross SS; Eaton C; Winder SJ
Prostate; 2013 Mar; 73(4):398-408. PubMed ID: 22996647
[TBL] [Abstract][Full Text] [Related]
2. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
3. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
4. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
[TBL] [Abstract][Full Text] [Related]
5. Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.
Mathew G; Mitchell A; Down JM; Jacobs LA; Hamdy FC; Eaton C; Rosario DJ; Cross SS; Winder SJ
Sci Rep; 2013 Sep; 3():2792. PubMed ID: 24077328
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
7. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
9. γ-Secretase Dependent Nuclear Targeting of Dystroglycan.
Leocadio D; Mitchell A; Winder SJ
J Cell Biochem; 2016 Sep; 117(9):2149-57. PubMed ID: 26990187
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
11. YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.
Collak FK; Demir U; Sagir F
Pathol Oncol Res; 2020 Apr; 26(2):867-876. PubMed ID: 30859486
[TBL] [Abstract][Full Text] [Related]
12. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
[TBL] [Abstract][Full Text] [Related]
14. Loss of dystroglycan function in oesophageal cancer.
Parberry-Clark C; Bury JP; Cross SS; Winder SJ
Histopathology; 2011 Aug; 59(2):180-7. PubMed ID: 21884196
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
16. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.
Sgambato A; De Paola B; Migaldi M; Di Salvatore M; Rettino A; Rossi G; Faraglia B; Boninsegna A; Maiorana A; Cittadini A
J Cell Physiol; 2007 Nov; 213(2):528-39. PubMed ID: 17516554
[TBL] [Abstract][Full Text] [Related]
17. Anomalous dystroglycan in carcinoma cell lines.
Losasso C; Di Tommaso F; Sgambato A; Ardito R; Cittadini A; Giardina B; Petrucci TC; Brancaccio A
FEBS Lett; 2000 Nov; 484(3):194-8. PubMed ID: 11078877
[TBL] [Abstract][Full Text] [Related]
18. [MTBP regulates migration and invasion of prostate cancer cells
Xiao Z; Chen M; Yang J; Yang C; Lü X; Tian H; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):6-12. PubMed ID: 30692060
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.
Zhu G; Yan W; He HC; Bi XC; Han ZD; Dai QS; Ye YK; Liang YX; Wang J; Zhong W
Mol Med; 2009; 15(11-12):363-70. PubMed ID: 19707524
[TBL] [Abstract][Full Text] [Related]
20. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.
Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D
BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
